Cargando…
Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia
Although current malaria therapies inhibit pathways encoded in the parasite’s genome, we have looked for anti-malaria drugs that can target an erythrocyte component because development of drug resistance might be suppressed if the parasite cannot mutate the drug’s target. In search for such erythroc...
Autores principales: | Kesely, Kristina, Noomuna, Panae, Vieth, Michal, Hipskind, Philip, Haldar, Kasturi, Pantaleo, Antonella, Turrini, Francesco, Low, Philip S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660480/ https://www.ncbi.nlm.nih.gov/pubmed/33180822 http://dx.doi.org/10.1371/journal.pone.0242372 |
Ejemplares similares
-
Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia
por: Kesely, Kristina R., et al.
Publicado: (2016) -
Imatinib augments standard malaria combination therapy without added toxicity
por: Chien, Huynh Dinh, et al.
Publicado: (2021) -
Induction of high tolerance to artemisinin by sub-lethal administration: A new in vitro model of P. falciparum
por: De Lucia, Serena, et al.
Publicado: (2018) -
Syk Kinase Inhibitors Synergize with Artemisinins by Enhancing Oxidative Stress in Plasmodium falciparum-Parasitized Erythrocytes
por: Tsamesidis, Ioannis, et al.
Publicado: (2020) -
VAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2013)